Project Grant T32HL176440
Award Date 9/1/25
Completion Date 8/31/30
Dollars Obligated $201K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
- This $373,168 Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the Postdoctoral Research Training in Child Health Equity program at Rhode Island Hospital, a division of Lifespan Corporation. The program aims to address persistent health inequities in pediatric conditions such as asthma, obesity, and sleep problems that disproportionately impact minoritized and socioeconomically under-resourced children. The training...
- This Project Grant award, valued at $167,400.00 and awarded by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), will support research by Brigham & Women's Hospital Inc. to investigate how the immune mediator CD70 regulates endothelial metabolism and function, with the goal of identifying novel therapeutic targets for atherosclerotic cardiovascular disease. The 5-year project will comprehensively examine the role of CD70 in impairing endothelial...
- This federal Project Grant award of $430,606 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to create a new Pediatric Cardiorespiratory Research Training Program at Vanderbilt University Medical Center (VUMC). The goal is to provide 2-3 years of highly rigorous research training for pediatrics fellows and PhD scientists to facilitate their transition to tenure-track faculty positions as clinician-scientists. The program will support up to 2...
- This federal Project Grant award of $193,984 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research to investigate the interplay between inflammation, angiogenesis, myocardial perfusion, and myocardial function in patients with advanced chronic kidney disease (CKD). The project, conducted by Brigham & Women's Hospital Inc., aims to mechanistically explore cardiovascular health before and after kidney transplantation. Key objectives...
- The federal Project Grant award of $131,886 was provided by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System, to conduct research on the use of bioimpedance as a tool to assess volume status and predict cardiovascular outcomes in patients with chronic kidney disease. The study aims to 1) examine the predictive capacity of changes in volume measured by bioimpedance for...
- This Project Grant award of $784,362.00, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) to Brigham & Women's Hospital Inc., will support research investigating the role of body composition, coronary microvascular dysfunction, and heart failure with preserved ejection fraction in characterizing adverse cardiometabolic disease phenotypes. The research aims to leverage novel imaging technologies to identify mechanisms of...
- This $185,760 Project Grant was awarded on August 25, 2025 by the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) to Oregon Health & Science University. The grant aims to support the development of the necessary skills and training for the applicant to lead the advancement of cardiovascular disease (CVD) risk assessment for women. The key research objectives are to: 1) test sex-differences in the predictive performance of existing...
- The Project Grant award titled "IPEDIHEART: INTERDISCIPLINARY RESEARCH TRAINING PROGRAM FOR PEDIATRIC HEART DISEASE" is funded by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) for $200,938 from September 1, 2025 to August 31, 2030. The grant supports an interdisciplinary research training program at Duke University focused on advancing scientific understanding and treatment of pediatric and congenital heart diseases. The program aims to...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $189,000.00 to the University of Utah to support a 5-year mentored research program and plan. The goal is to develop the principal investigator into an independent, patient-oriented clinical researcher focused on the pathophysiology of cardiogenic shock and its overlap with cardiorenal syndrome. The central hypothesis is that angiotensin II deficiency in a...
- The Regents of the University of Michigan were awarded a $207,342 Project Grant from the National Heart Lung and Blood Institute's Cardiovascular Diseases Research program (CFDA 93.837) on September 12, 2025. The goal of this 5-year program is to enhance research training and career development opportunities for Emergency Medicine (EM) resident investigators at the University of Michigan. The program will recruit and train 2 outstanding EM resident trainees annually, providing them with 12...